Ursolic Acid Ameliorated Neuronal Damage by Restoring Microglia-Activated MMP/TIMP Imbalance in vitro

References

• Shah ASV, Lee KK, Perez JAR, et al. Clinical burden, risk factor impact and outcomes following myocardial infarction and stroke: a 25-year individual patient level linkage study. Lancet Reg Health Eur. 2021;7:100141. doi:10.1016/j.lanepe.2021.100141
   PubMedGoogle Scholar
• Campbell BCV, Khatri P. Stroke. Lancet. 2020;396(10244):129–142. doi:10.1016/S0140-6736(20)31179-X
   PubMed Web of Science ®Google Scholar
• Chovsepian A, Berchtold D, Winek K, et al. A primeval mechanism of tolerance to desiccation based on glycolic acid saves neurons in mammals from ischemia by reducing intracellular calcium-mediated excitotoxicity. Adv Sci. 2022;9(4):e2103265. doi:10.1002/advs.202103265
   Web of Science ®Google Scholar
• Ni XC, Wang HF, Cai YY, et al. Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke. Redox Biol. 2022;54:102363. doi:10.1016/j.redox.2022.102363
   PubMed Web of Science ®Google Scholar
• Xu J, Zhao J, Wang R, et al. Shh and Olig2 sequentially regulate oligodendrocyte differentiation from hiPSCs for the treatment of ischemic stroke. Theranostics. 2022;12(7):3131–3149. doi:10.7150/thno.69217
   PubMed Web of Science ®Google Scholar
• Ahmed N, Nasman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke. 2000;31(6):1250–1255. doi:10.1161/01.str.31.6.1250
   PubMed Web of Science ®Google Scholar
• Investigators RBT, Qiu Z, Li F, et al. Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke: the RESCUE BT randomized clinical trial. JAMA. 2022;328(6):543–553. doi:10.1001/jama.2022.12584
   PubMed Web of Science ®Google Scholar
• Toul M, Mican J, Slonkova V, et al. Hidden potential of highly efficient and widely accessible thrombolytic staphylokinase. Stroke. 2022:101161STROKEAHA122040219. doi:10.1161/STROKEAHA.122.040219
   Web of Science ®Google Scholar
• Wang Y, Leak RK, Cao G. Microglia-mediated neuroinflammation and neuroplasticity after stroke. Front Cell Neurosci. 2022;16:980722. doi:10.3389/fncel.2022.980722
   PubMed Web of Science ®Google Scholar
• Wicks EE, Ran KR, Kim JE, Xu R, Lee RP, Jackson CM. The translational potential of microglia and monocyte-derived macrophages in ischemic stroke. Front Immunol. 2022;13:897022. doi:10.3389/fimmu.2022.897022
   PubMed Web of Science ®Google Scholar
• Leonardo CC, Hall AA, Collier LA, Gottschall PE, Pennypacker KR. Inhibition of gelatinase activity reduces neural injury in an ex vivo model of hypoxia-ischemia. Neuroscience. 2009;160(4):755–766. doi:10.1016/j.neuroscience.2009.02.080
   PubMed Web of Science ®Google Scholar
• Liou CJ, Yang CM, Lee TH, Liu PS, Hsieh HL. Neuroprotective effects of dehydroepiandrosterone sulfate through inhibiting expression of matrix metalloproteinase-9 from bradykinin-challenged astroglia. Mol Neurobiol. 2019;56(1):736–747. doi:10.1007/s12035-018-1125-6
   PubMed Web of Science ®Google Scholar
• Mashaqi S, Mansour HM, Alameddin H, et al. Matrix metalloproteinase-9 as a messenger in the cross talk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review. J Clin Sleep Med. 2021;17(3):567–591. doi:10.5664/jcsm.8928
   PubMed Web of Science ®Google Scholar
• Liu S, Liu J, Wang Y, et al. Differentially expressed genes induced by beta-caryophyllene in a rat model of cerebral ischemia-reperfusion injury. Life Sci. 2021;273:119293. doi:10.1016/j.lfs.2021.119293
   PubMed Web of Science ®Google Scholar
• Sanchez-Blazquez P, Pozo-Rodrigalvarez A, Merlos M, Garzon J. The sigma-1 receptor antagonist, S1RA, reduces stroke damage, ameliorates post-stroke neurological deficits and suppresses the overexpression of MMP-9. Mol Neurobiol. 2018;55(6):4940–4951. doi:10.1007/s12035-017-0697-x
   PubMed Web of Science ®Google Scholar
• Svedin P, Hagberg H, Sävman K, Zhu C, Mallard C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci. 2007;27(7):1511–1518. doi:10.1523/jneurosci.4391-06.2007
   PubMed Web of Science ®Google Scholar
• Gong QY, Cai L, Jing Y, et al. Urolithin A alleviates blood-brain barrier disruption and attenuates neuronal apoptosis following traumatic brain injury in mice. Neural Regenerat Res. 2022;17(9):2007–2013. doi:10.4103/1673-5374.335163
   PubMed Web of Science ®Google Scholar
• Qiu J, Chen Y, Zhuo J, et al. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson’s disease model. Neuropharmacology. 2022;207:108963. doi:10.1016/j.neuropharm.2022.108963
   PubMed Web of Science ®Google Scholar
• Wang Y, He Z, Deng S. Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury. Drug Des Devel Ther. 2016;10:1663–1674. doi:10.2147/dddt.S103829
   PubMed Web of Science ®Google Scholar
• Natunen TA, Gynther M, Rostalski H, Jaako K, Jalkanen AJ. Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target. Basic Clin Pharmacol Toxicol. 2019;124(1):40–49. doi:10.1111/bcpt.13094
   PubMed Web of Science ®Google Scholar
• Zhou X, Spittau B. Lipopolysaccharide-induced microglia activation promotes the survival of midbrain dopaminergic neurons in vitro. Neurotox Res. 2018;33(4):856–867. doi:10.1007/s12640-017-9842-6
   PubMed Web of Science ®Google Scholar
• Yin X, Feng L, Ma D, et al. Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone. J Neuroinflammation. 2018;15(1):97. doi:10.1186/s12974-018-1127-3
   PubMedGoogle Scholar
• Wang R, Bao H, Zhang S, Li R, Chen L, Zhu Y. miR-186-5p promotes apoptosis by targeting IGF-1 in SH-SY5Y OGD/R model. Int J Biol Sci. 2018;14(13):1791–1799. doi:10.7150/ijbs.25352
   PubMed Web of Science ®Google Scholar
• Liang J, Yu Y, Wang B, et al. Ginsenoside Rb1 attenuates oxygen-glucose deprivation-induced apoptosis in SH-SY5Y cells via protection of mitochondria and inhibition of AIF and cytochrome c release. Molecules. 2013;18(10):12777–12792. doi:10.3390/molecules181012777
   PubMed Web of Science ®Google Scholar
• Ventayol M, Vinas JL, Sola A, et al. miRNA let-7e targeting MMP9 is involved in adipose-derived stem cell differentiation toward epithelia. Cell Death Dis. 2014;5:e1048. doi:10.1038/cddis.2014.2
   PubMed Web of Science ®Google Scholar
• Souvenir R, Fathali N, Ostrowski RP, Lekic T, Zhang JH, Tang J. Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia. Neurobiol Dis. 2011;44(1):28–37. doi:10.1016/j.nbd.2011.05.020
   PubMed Web of Science ®Google Scholar
• Lin L, Que Y, Lu P, et al. Chidamide inhibits acute myeloid leukemia cell proliferation by lncRNA VPS9D1-AS1 downregulation via MEK/ERK signaling pathway. Front Pharmacol. 2020;11:569651. doi:10.3389/fphar.2020.569651
   PubMed Web of Science ®Google Scholar
• Huang P, Wan H, Shao C, Li C, Zhang L, He Y. Recent advances in Chinese herbal medicine for cerebral ischemic reperfusion injury. Front Pharmacol. 2021;12:688596. doi:10.3389/fphar.2021.688596
   PubMed Web of Science ®Google Scholar
• Wang Y, Li L, Deng S, Liu F, He Z. Ursolic acid ameliorates inflammation in cerebral ischemia and reperfusion injury possibly via high mobility group Box 1/Toll-Like Receptor 4/NFkappaB pathway. Front Neurol. 2018;9:253. doi:10.3389/fneur.2018.00253
   PubMed Web of Science ®Google Scholar
• Rauchmann BS, Brendel M, Franzmeier N, et al. Microglial activation and connectivity in Alzheimer disease and aging. Ann Neurol. 2022;92(5):768–781. doi:10.1002/ana.26465
   PubMed Web of Science ®Google Scholar
• Nguyen HM, Grossinger EM, Horiuchi M, et al. Differential Kv1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microglia. Glia. 2017;65(1):106–121. doi:10.1002/glia.23078
   PubMed Web of Science ®Google Scholar
• Slate JR, Chriswell BO, Briggs RE, McGill JL. The effects of ursolic acid treatment on immunopathogenesis following mannheimia haemolytica infections. Front Vet Sci. 2021;8:782872. doi:10.3389/fvets.2021.782872
   PubMed Web of Science ®Google Scholar
• Meng RY, Jin H, Nguyen TV, Chai OH, Park BH, Kim SM. Ursolic acid accelerates paclitaxel-induced cell death in esophageal cancer cells by suppressing Akt/FOXM1 signaling cascade. Int J Mol Sci. 2021;22(21):11486. doi:10.3390/ijms222111486
   PubMed Web of Science ®Google Scholar
• Njau F, Haller H. Calcium dobesilate modulates PKCdelta-NADPH Oxidase- MAPK-NF-kappaB signaling pathway to reduce CD14, TLR4, and MMP9 expression during monocyte-to-macrophage differentiation: potential therapeutic implications for atherosclerosis. Antioxidants. 2021;10:11.
   Web of Science ®Google Scholar
• Kim H, Roh Y, Yong Park S, et al. In vitro and in vivo anti-tumor efficacy of krill oil against bladder cancer: involvement of tumor-associated angiogenic vasculature. Food Res Int. 2022;156:111144. doi:10.1016/j.foodres.2022.111144
   PubMed Web of Science ®Google Scholar
• Zhang M, Meng X, Pan Y, et al. Predictive values of baseline matrix metalloproteinase 9 levels in peripheral blood on 3-month outcomes of high-risk patients with minor stroke or transient ischemic attack. Eur J Neurol. 2022;29:2976–2986. doi:10.1111/ene.15342
   PubMed Web of Science ®Google Scholar
• Morancho A, Rosell A, García-Bonilla L, Montaner J. Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Ann N Y Acad Sci. 2010;1207:123–133. doi:10.1111/j.1749-6632.2010.05734.x
   PubMed Web of Science ®Google Scholar
• Fujimoto M, Takagi Y, Aoki T, et al. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(10):1674–1685. doi:10.1038/jcbfm.2008.59
   PubMed Web of Science ®Google Scholar
• Lee J, Kim YS, Choi DH, et al. Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia. J Biol Chem. 2004;279(51):53725–53735. doi:10.1074/jbc.M407627200
   PubMed Web of Science ®Google Scholar
• Bi XL, Yang JY, Dong YX, et al. Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol. 2005;5(1):185–193. doi:10.1016/j.intimp.2004.08.008
   PubMed Web of Science ®Google Scholar
• Henn A, Lund S, Hedtjarn M, Schrattenholz A, Porzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX. 2009;26(2):83–94. doi:10.14573/altex.2009.2.83
   PubMedGoogle Scholar
• Crotti A, Benner C, Kerman BE, et al. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci. 2014;17(4):513–521. doi:10.1038/nn.3668
   PubMed Web of Science ®Google Scholar
• Yew WP, Djukic ND, Jayaseelan JSP, Woodman RJ, Muyderman H, Sims NR. Differential effects of the cell cycle inhibitor, olomoucine, on functional recovery and on responses of peri-infarct microglia and astrocytes following photothrombotic stroke in rats. J Neuroinflammation. 2021;18(1):168. doi:10.1186/s12974-021-02208-w
   PubMed Web of Science ®Google Scholar
• Spurgat MS, Tang SJ. Single-Cell RNA-sequencing: astrocyte and microglial heterogeneity in health and disease. Cells. 2022;11(13):2021. doi:10.3390/cells11132021
   PubMed Web of Science ®Google Scholar